The Value of Continuous Noninvasive Hemoglobin Monitoring Using Masimo Radical -7 Pulse CO-Oximeter in Intraoperative Blood Transfusion Practice During Obstetric Procedures
1 other identifier
observational
60
1 country
1
Brief Summary
The principle aim of this study is to detect the accurracy of Masimo Radical-7¿ Pulse CO-Oximeter in relation to laboratory hemoglobin and estimated blood loss in intraoperative blood transfusion practice during obstetric procedures with high risk of bleeding.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 11, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 23, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2017
CompletedFirst Submitted
Initial submission to the registry
December 29, 2017
CompletedFirst Posted
Study publicly available on registry
January 24, 2018
CompletedMarch 29, 2018
March 1, 2018
1.7 years
December 29, 2017
March 28, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Transfusion improvement
Improvement of transfusion practice by detecting the amount of transfused units of RBCs during rapid blood loss
24 hours
Secondary Outcomes (1)
Agreement between SpHb and laboratory Hb values
24 hours
Study Arms (1)
Continuous Hb monitoring with Masimo Radical
Plethysmography Variability Index (PVI) is a measure of the dynamic changes in the perfusion index (PI) that occur during the respiratory cycle . PVI = ﴾PI Max - PI Min﴿ ÷ PI Maxx 100 %. PVI has the potential to provide useful information concerning changes in the balance between intrathoracic airway pressure and intravascular fluid volume. Trending of PVI may be useful in monitoring surgical patients, both intraoperatively and postoperatively, for appropriate hydration states. For example, a rising PVI may indicate developing hypovolemia and gives an alarm for the need of appropriate fluid and or blood products transfusion supported by the patient hemoglobin level
Interventions
The Masimo pulse oximetry model: The pulse oximetry model which Masimo developed accounts for saturation values contributed by the true arterial signal, and by one or more motion or noise signals. lt is assumed that under conditions of motion, the detected IR and RD signals comprise both the true arterial saturation signal and a venous (or non-arterial) motion noise signal. Masimo uses a highly sophisticated adaptive filter with, Discrete saturation transform (DST) four other parallel engines, to leverage each algorithm's unique strengths to ensure accurate readings through all patient conditions. Masimo SET's most powerful algorithm is Signal extraction technology (SET). All algorithms depend upon assumptions. The more assumptions, the weaker the algorithm. DST makes only one assumption -that arterial blood has a higher oxygenation than venous - making it the most powerful pulse oximetry algorithm
Eligibility Criteria
Basic subject demographics summary of age, weight, height, patient position, basal lab Hb, and start time of ADC. Basic summary of number of patients, estimated blood loss, transfusions, fluids given, mean arterial blood pressure, central venous pressure, fomites number and urine output.
You may qualify if:
- All adult high risk patients (ASA 1-2)
- Age group (16-44 years old)
- Obtetric surgery with high risk of bleeding in early and late pregnancy e.g Disturbed ectopic pregnancy ,Vesicular mole , Abortion , Placenta accrete , Rupture uterus and placenta previa
You may not qualify if:
- Significant liver disease defined as (serum alanine aminotransferase and serum aspartate aminotransferase \>2.5 times normal).
- Significant renal disease defined as (serum creatinine \>1.5 mg/dl or creatinine clearance \<40 ml/min).
- Significant coagulopathy defined as (INR \>1.5).
- Use of antiplatlets or anticoagulants.
- Anemic patients with Hb% less than 8 gm/dl
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
- Mohamed, Ahmed A., M.D.collaborator
- Ashraf Mohamed Abd Elmawgodcollaborator
- Abdelhamid, Bassant Mohamed, M.D.collaborator
- Hossam Eldin Mostafa Yahiacollaborator
Study Sites (1)
Ahmed Abdalla Mohamed
Cairo, 11451, Egypt
Study Officials
- STUDY CHAIR
Ashraf Abdelmawgood, M.D
Professor of Anesthesia&I.C.U and Pain Clinic
- STUDY DIRECTOR
Hossam El Din Mostafa, M.S
Assistant Lecturer of Anesthesia&I.C.U and Pain Clinic
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Anesthesia&I.C.U and Pain Clinic
Study Record Dates
First Submitted
December 29, 2017
First Posted
January 24, 2018
Study Start
April 11, 2016
Primary Completion
December 23, 2017
Study Completion
December 28, 2017
Last Updated
March 29, 2018
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share
Via scholar Gate